David W. Goodman, MD: New Treatments Coming for ADHD

Video

Treatment for ADHD is similar for adolescents and adult patients.

There are a number of new treatments and therapies coming on board for attention deficit/hyperactivity disorder (ADHD).

During the annual Neuroscience Education Institute Max! Virtual meeting, David Goodman, MD, FAPA, assistant professor of psychiatry and behavioral sciences at Johns Hopkins School of Medicine, will present 5 different times about ADHD and some new insights into the disorder.

Goodman explained some of the confusion in ADHD he will address during 1 of his presentations will be the hierarchy of ADHD treatments. Currently, there are at least 29 different ADHD treatments coming from multiple medication families, leading to some confusion among doctors over what the right treatment ultimately is.

Goodman will also look at what the options are for doctors should a patient not respond to the first option for ADHD treatment.

He will also take a deeper dive into dosing during the virtual conference, trying to come up with a best practices checklist clinicians can use to find the right dosing for a given patient.

In the final presentation, Goodman will look at the connection between autism and ADHD and what the common comorbidities could be.

Recent Videos
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
Boadie Dunlop, MD, Weighs in on FDA Advisory Vote on Lykos’ MDMA
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Signs and Symptoms of Connective Tissue Disease
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
© 2024 MJH Life Sciences

All rights reserved.